Sun Pharmaceutical Alfuzosin Tablets Recall: Foreign Wire in Tablets
Sun Pharmaceutical recalls 10mg Alfuzosin tablets with foreign wire pieces. Consumers should stop using affected lots due to potential injury from embedded wire fragments.
Stop using this now
Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment.
Contact the company
What happened, in plain English
Sun Pharmaceutical is recalling 10mg Alfuzosin Hydrochloride Extended-release Tablets that contain broken wire pieces from manufacturing equipment. This could cause injury if the wire fragments break off inside the body. Read more at govinfonow.com/recall/42098-sun-pharmaceutical-alfuzosin-tablets-recall-foreign-wire-in-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/42098-sun-pharmaceutical-alfuzosin-tablets-recall-foreign-wire-in-tablets · Updated October 8, 2026 · FDA enforcement record: FDA #D-0502-2017
Cite this page
“Sun Pharmaceutical Alfuzosin Tablets Recall: Foreign Wire in Tablets.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42098-sun-pharmaceutical-alfuzosin-tablets-recall-foreign-wire-in-tablets. Based on FDA recall #D-0502-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0502-2017%22&limit=1).
Why it’s dangerous
The tablets contain small pieces of wire rope from manufacturing equipment that can become embedded in the body. If these fragments break off inside the body, they could cause injury or infection.
Who’s affected
People with a prescription for Alfuzosin Hydrochloride Extended-release Tablets, 10mg, 100-count bottles. Those who have the specific lot numbers listed in the recall are most at risk.
How to tell if you have this one
Check your prescription bottle for the brand name Sun Pharmaceutical, 10mg Alfuzosin Hydrochloride Extended-release Tablets, 100-count. Look for lot numbers JKR5219A, JKR5200A, JKR5220A, JKR5221A, or JKR5222A that expire by March 2018.
- Brand
Sun Pharmaceutical- Category
Drug
What to do — step by step
Stop Using Tablets Now
Immediately stop using any affected tablets as they contain foreign wire fragments that could cause injury.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 18 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Sun Pharmaceutical recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0502-2017 (January 5, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0502-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.